Abstrakt

Gene Expression Monitoring in Pediatric Heart Transplant recipients

S S Goonewardene and PRajjayabun

AlloMap gene expression testing is a non-invasive screening tool approved for use in heart transplant recipients age 15 and older. Experience with AlloMap in pediatric heart transplant recipients is limited. We sought to describe the variations in AlloMap scores seen in pediatric heart transplant recipients.